← Leaderboards
Allison B Reiss
New York University School Of Medicine
$1,032,144
Attributed
$1,032,144
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $227.4K · FY2005–14$250K$187.5K$125K$62.5K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$1,032,144 · 3
By mechanism
R01$678,818 · 1
R21$353,326 · 1
M01$0 · 1
Top collaborators
No co-investigators on record.
Most similar at New York University School Of Medicine
Same institution · by research overlap
- Bruce Neil Cronstein$53,680,413
- Jill P Buyon$29,367,681
- Simon Karpatkin$8,225,232
- Paulo G Coelho$2,529,553
- Chuanshu Huang$11,325,976
Others in their field
Top investigators on “Atherosclerosis”
- Eric A Boerwinkle · University Of Texas Hlth Sci Ctr Houston$63,519,256
- Josef Coresh · New York University School Of Medicine$60,445,875
- Daniel James Rader · University Of Pennsylvania$50,278,074
- Howard N Hodis · University Of Southern California$49,943,399
- Gary K Owens · University Of Virginia$42,472,259
- Alan Richard Tall · Columbia University Health Sciences$38,866,887
Research focus
AtherosclerosisSystemic Lupus ErythematosusImmune ComplexHuman SubjectClinical ResearchImmune ResponseRheumatoid ArthritisTissue /Cell CultureLaboratory MouseHomeostasisMacrophageDisease /Disorder OnsetPurinergic ReceptorInflammationCholesterolEnzyme Induction /RepressionComorbidityComplement PathwayMitogen Activated Protein KinaseAtherogenesisArteriesAnimal ModelArterial Fatty StreakBone Marrow
Grant awards (7)
Resveratrol as an Innovative Cardiovascular Therapeutic Strategy in Lupus$192,110
R21 · FY2014 · AT · contact PI
Resveratrol as an Innovative Cardiovascular Therapeutic Strategy in Lupus$161,216
R21 · FY2013 · AT · contact PI
Immune Reactants, Cholesterol and Atherosclerosis$223,545
R01 · FY2006 · HL · contact PI
Immune Reactants, Cholesterol and Atherosclerosis$227,353
R01 · FY2005 · HL
Immune Reactants, Cholesterol and Atherosclerosis$227,920
R01 · FY2004 · HL
IMMUNOLOGICAL MECHANISMS IN PREMATURE ATHEROSCLEROSIS$0
M01 · FY2000 · RR
IMMUNOLOGICAL MECHANISMS IN PREMATURE ATHEROSCLEROSIS$0
M01 · FY2000 · RR